JP2019529506A5 - - Google Patents

Download PDF

Info

Publication number
JP2019529506A5
JP2019529506A5 JP2019517968A JP2019517968A JP2019529506A5 JP 2019529506 A5 JP2019529506 A5 JP 2019529506A5 JP 2019517968 A JP2019517968 A JP 2019517968A JP 2019517968 A JP2019517968 A JP 2019517968A JP 2019529506 A5 JP2019529506 A5 JP 2019529506A5
Authority
JP
Japan
Prior art keywords
zinc
species
logk
formulation
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019517968A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019529506A (ja
Filing date
Publication date
Priority claimed from GBGB1616509.4A external-priority patent/GB201616509D0/en
Priority claimed from GBGB1617866.7A external-priority patent/GB201617866D0/en
Priority claimed from GBGB1707190.3A external-priority patent/GB201707190D0/en
Application filed filed Critical
Priority claimed from PCT/GB2017/052941 external-priority patent/WO2018060736A1/en
Publication of JP2019529506A publication Critical patent/JP2019529506A/ja
Publication of JP2019529506A5 publication Critical patent/JP2019529506A5/ja
Priority to JP2022132329A priority Critical patent/JP2022176989A/ja
Priority to JP2024110933A priority patent/JP2024153677A/ja
Pending legal-status Critical Current

Links

JP2019517968A 2016-09-29 2017-09-29 新規の製剤 Pending JP2019529506A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022132329A JP2022176989A (ja) 2016-09-29 2022-08-23 新規の製剤
JP2024110933A JP2024153677A (ja) 2016-09-29 2024-07-10 新規の製剤

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1616509.4A GB201616509D0 (en) 2016-09-29 2016-09-29 Novel formulations
GB1616509.4 2016-09-29
GBGB1617866.7A GB201617866D0 (en) 2016-10-21 2016-10-21 Novel formulations
GB1617866.7 2016-10-21
GBGB1707190.3A GB201707190D0 (en) 2017-05-05 2017-05-05 Novel Formulations
GB1707190.3 2017-05-05
PCT/GB2017/052941 WO2018060736A1 (en) 2016-09-29 2017-09-29 Novel formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022132329A Division JP2022176989A (ja) 2016-09-29 2022-08-23 新規の製剤

Publications (2)

Publication Number Publication Date
JP2019529506A JP2019529506A (ja) 2019-10-17
JP2019529506A5 true JP2019529506A5 (https=) 2020-11-26

Family

ID=60037644

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2019517947A Active JP7145849B2 (ja) 2016-09-29 2017-09-29 新規の製剤
JP2019517968A Pending JP2019529506A (ja) 2016-09-29 2017-09-29 新規の製剤
JP2022132329A Pending JP2022176989A (ja) 2016-09-29 2022-08-23 新規の製剤
JP2022148894A Pending JP2022180499A (ja) 2016-09-29 2022-09-20 新規の製剤
JP2024110933A Pending JP2024153677A (ja) 2016-09-29 2024-07-10 新規の製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019517947A Active JP7145849B2 (ja) 2016-09-29 2017-09-29 新規の製剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022132329A Pending JP2022176989A (ja) 2016-09-29 2022-08-23 新規の製剤
JP2022148894A Pending JP2022180499A (ja) 2016-09-29 2022-09-20 新規の製剤
JP2024110933A Pending JP2024153677A (ja) 2016-09-29 2024-07-10 新規の製剤

Country Status (13)

Country Link
US (3) US20190282667A1 (https=)
EP (3) EP3518893A1 (https=)
JP (5) JP7145849B2 (https=)
KR (1) KR102482664B1 (https=)
CN (2) CN109803639B (https=)
AU (2) AU2017334289B2 (https=)
CA (2) CA3034971C (https=)
DK (1) DK3518892T5 (https=)
ES (1) ES2954180T3 (https=)
IL (1) IL265609B2 (https=)
MX (1) MX2019003611A (https=)
PL (1) PL3518892T3 (https=)
WO (2) WO2018060736A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
DK3518892T5 (da) * 2016-09-29 2024-09-02 Arecor Ltd Farmaceutisk formulering, der indeholder en insulinforbindelse
GB201707188D0 (en) * 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
IL277721B2 (en) 2018-04-04 2024-03-01 Arecor Ltd Medical infusion pump system for the delivery of an insulin compound
CA3094304A1 (en) * 2018-04-04 2019-10-10 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
CN112040928A (zh) * 2018-04-04 2020-12-04 艾瑞克有限公司 用于递送胰岛素化合物的医用输注泵系统
FR3084586B1 (fr) * 2018-08-03 2020-11-06 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes
WO2020190591A1 (en) * 2019-03-15 2020-09-24 Eli Lilly And Company Preserved formulations
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
GB201911461D0 (en) * 2019-08-09 2019-09-25 Arecor Ltd Novel composition
GB202004814D0 (en) 2020-04-01 2020-05-13 Arecor Ltd Novel formulations
EP4281039A2 (en) * 2021-01-25 2023-11-29 Mylan Ireland Limited Pharmaceutical glp peptide compositions and methods of preparation thereof
CN114887039B (zh) * 2022-05-13 2026-01-30 西北工业大学 一种锌离子介导的自组装胰岛素纳米药物、制备方法和应用

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI78616C (fi) 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
KR910700262A (ko) 1988-12-23 1991-03-14 안네 제케르 사람 인슐린 유사체
PT93057B (pt) 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
JP3122128B2 (ja) 1989-12-21 2001-01-09 ノボ ノルディスク アクティーゼルスカブ ペプチド製剤
AU3562195A (en) 1994-10-04 1996-04-26 Novo Nordisk A/S Preparations containing aspb28 human insulin and nicotinamide
WO1997017945A2 (en) 1995-11-13 1997-05-22 Minimed, Inc. Methods and compositions for the delivery of monomeric proteins
US5866538A (en) 1996-06-20 1999-02-02 Novo Nordisk A/S Insulin preparations containing NaCl
DK1283051T3 (da) 1997-06-13 2006-10-16 Lilly Co Eli Stabile insulinformuleringer
EP1044016B1 (en) 1998-01-09 2005-03-16 Novo Nordisk A/S Stabilised insulin compositions
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE602005014962D1 (de) 2004-03-12 2009-07-30 Biodel Inc Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
WO2006051103A2 (en) 2004-11-12 2006-05-18 Novo Nordisk A/S Stable formulations of peptides
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
WO2007041481A1 (en) 2005-09-29 2007-04-12 Biodel, Inc. Rapid acting and prolonged acting insulin preparations
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
JP2009512709A (ja) 2005-10-20 2009-03-26 エムディーアールエヌエー,インコーポレイテッド 速効型インスリンの経鼻投与
CN101340893B (zh) * 2005-10-20 2012-03-21 玛瑞纳生物技术有限公司 速效胰岛素的鼻内施用
WO2007121256A2 (en) 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
US8173594B2 (en) 2006-06-23 2012-05-08 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US7998927B2 (en) 2006-06-23 2011-08-16 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US8084022B2 (en) 2006-06-23 2011-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
WO2007149096A1 (en) * 2006-06-23 2007-12-27 Aegis Therapeutics, Inc. Stabilizing alkylglycoside compositions and methods thereof
GB0700523D0 (en) 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
WO2009114959A1 (zh) * 2008-03-20 2009-09-24 中国人民解放军军事医学科学院毒物药物研究所 可注射用缓释药物制剂及其制备方法
TWI394580B (zh) 2008-04-28 2013-05-01 Halozyme Inc 超快起作用胰島素組成物
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
WO2010115819A1 (en) 2009-03-31 2010-10-14 Sanofi-Aventis Deutschland Gmbh Mounting arrangement and coupling assembly for a drug-delivery device
AU2010264636B2 (en) 2009-06-26 2013-06-27 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
CN101912600B (zh) 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
WO2011094632A1 (en) * 2010-01-29 2011-08-04 The Uab Research Foundation Method for administration of insulin and pharmaceutical composition thereof
US20120178675A1 (en) 2010-07-07 2012-07-12 Biodel Inc. Compositions And Methods For Modulating The Pharmacokinetics and Pharmacodynamics of Insulin
JP2013545782A (ja) 2010-12-14 2013-12-26 ノヴォ ノルディスク アー/エス 長時間作用型インスリンと組み合わせた速効型インスリン
JP5950477B2 (ja) 2011-08-10 2016-07-13 アドシア 少なくとも1種の基礎インスリンの注射溶液
WO2013067022A1 (en) * 2011-10-31 2013-05-10 Xeris Pharmaceuticals, Inc. Formulations for the treatment of diabetes
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
EP3130347B1 (en) 2011-12-30 2019-09-18 Halozyme, Inc. Ph20 polypeptide variants, formulations and uses thereof
US9381247B2 (en) 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US9399065B2 (en) 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
EP2919804B1 (fr) 2012-11-13 2018-01-31 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
US9707275B2 (en) * 2012-12-19 2017-07-18 Wockhardt Limited Stable aqueous composition comprising human insulin or an analogue or derivative thereof
TWI780236B (zh) 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
AR098168A1 (es) 2013-10-25 2016-05-04 Sanofi Sa Formulación estable de insulina glulisina
US9895423B2 (en) * 2014-01-09 2018-02-20 Sanofi Stabilized pharmaceutical formulations of insulin aspart
JP6723921B2 (ja) * 2014-01-09 2020-07-15 サノフイSanofi インスリンアナログおよび/またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤
GB2525838B (en) 2014-01-30 2020-12-30 Insulet Netherlands B V Actuator and actuation method
WO2015120457A1 (en) 2014-02-10 2015-08-13 Biodel Inc. Stabilized ultra-rapid-acting insulin formulations
TWI685348B (zh) 2014-05-08 2020-02-21 美國禮來大藥廠 速效胰島素組合物
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020952B1 (fr) 2014-05-14 2017-09-08 Adocia Formulation a action rapide d'insuline comprenant un compose anionique substitue et un compose polyanionique
DK3006045T3 (en) 2014-10-07 2017-07-17 Cyprumed Gmbh Pharmaceutical formulations for oral administration of peptide or protein drugs
AR102869A1 (es) * 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
DK3518892T5 (da) 2016-09-29 2024-09-02 Arecor Ltd Farmaceutisk formulering, der indeholder en insulinforbindelse
JP2018140127A (ja) 2017-02-28 2018-09-13 株式会社三洋物産 遊技機
GB201707189D0 (en) * 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707187D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
GB201707188D0 (en) 2017-05-05 2017-06-21 Arecor Ltd Novel formulations
CN112040928A (zh) 2018-04-04 2020-12-04 艾瑞克有限公司 用于递送胰岛素化合物的医用输注泵系统
CA3094304A1 (en) 2018-04-04 2019-10-10 Arecor Limited Medical infusion pump system for the delivery of an insulin compound
IL277721B2 (en) 2018-04-04 2024-03-01 Arecor Ltd Medical infusion pump system for the delivery of an insulin compound

Similar Documents

Publication Publication Date Title
JP2019529506A5 (https=)
JP2019533656A5 (https=)
US20260102473A1 (en) Novel formulations
CN110582285B (zh) 稳定的胰岛素制剂
WO2018203061A1 (en) Stable insulin formulations
IL277731B2 (en) Medical infusion pump system for the delivery of an insulin compound
JP2021520365A5 (https=)
JP2020518636A5 (https=)
US20210113763A1 (en) Medical infusion pump system for the delivery of an insulin compound
EP3773474B1 (en) Medical infusion pump system for the delivery of an insulin compound
CA3094308C (en) Medical infusion pump system for the delivery of an insulin compound
HK40013219B (en) Pharmaceutical formulation comprising an insulin compound